The iShares Nasdaq Biotechnology ETF Fails Its First Post-Breakout Test
The iShares Nasdaq Biotechnology ETF (IBB) finally broke out above resistance from its downtrending 50-day moving average (DMA) on Wednesday, October 28th. This was the same day as the Federal Reserve’s October decision on monetary policy. Unfortunately, the breakout failed its first test as it stopped cold right at the low of the “Clinton Bash” … Read more